News

Core Scientific's Growth Boosts Price Target: Insights and Impacts

Core Scientific's Growth Boosts Price Target: Insights and Impacts

Price Target Adjustment for Core Scientific Shares

Recently, Canaccord Genuity announced a revised price target for Core Scientific Inc. (NASDAQ: CORZ), raising it from $16.00 to an impressive $17.00 while reaffirming its Buy rating. This change comes in light of significant developments where CoreWeave, a notable player in the AI hosting market, exercised its option for an additional supply of 118 MW of data center power.

This strategic move now sets the total contracted power for Core Scientific at a remarkable 500 MW dedicated to essential data center operations, plus an additional 200 MW for ancillary functions supporting these operations.

Strategic Operational Changes and Potential Growth

Core Scientific anticipates that these new contracts could yield around an 80% contribution-like margin due to the efficiencies gained through the expanded power supply. Furthermore, CoreWeave is expected to cover the estimated $180 million in capital expenditures required to enhance current infrastructure, enabling the provision of AI hosting services.

Looking beyond this current expansion, analysts outlined the potential for Core Scientific to substantially increase its power portfolio across existing sites. The company has strategically invested in brownfield assets, including old textile mills, which could significantly augment its ability to draw power from utility sources.

Expanding Infrastructure and Allocation Plans

Efforts are underway at Core Scientific to broaden power allocations at these strategic locations. Although the specifics regarding the transition from current Bitcoin mining operations to AI hosting capabilities are still unclear, the prospects for enhanced power allocation are deemed favorable for the overall stock performance of Core Scientific.

The proactive stance demonstrated by the company in upgrading its infrastructure and facilities is a crucial element backing the increased price target set by Canaccord Genuity.

Recent Developments in Service Contracts

In addition to the power expansion, Core Scientific has reported an exciting update regarding its high-performance computing (HPC) hosting offerings. CoreWeave has committed to an additional 120 MW of critical IT load at one of Core Scientific’s facilities. This new agreement is expected to generate approximately $2.0 billion in cumulative revenue over a 12-year period, raising total potential revenue from CoreWeave to a staggering $8.7 billion.

This kind of growth is significant for Core Scientific, especially as it diversifies its revenue streams and taps into the burgeoning AI sector. Furthermore, the recent sale of 375 bitcoins generated around $22.5 million, aiding in the repayment of $267 million in high-interest debt that was settled through proceeds from a convertible senior notes offering.

Leadership Changes and Market Outlook

On the leadership front, Core Scientific is preparing for changes as CFO Denise Sterling is set to depart by May 2025, sparking the initiation of a search for her successor. Analyst sentiments remain optimistic, with B.Riley elevating the price target for Core Scientific shares from $13.00 to $14.00 while keeping a Buy rating intact.

Core Scientific's Market Presence and Financial Health

Core Scientific’s developments align well with insightful metrics and meaningful data contributions regarding the company’s standing in the competitive landscape of data centers and AI hosting. Currently, the firm boasts a market cap of $3.54 billion and reported an impressive revenue increase of 8.25% over the past year, accompanied by a quarterly growth rate of 11.18% in Q2 of the current fiscal year.

The new contract with CoreWeave in conjunction with ongoing efforts to amplify power allocations at current sites highlights a promising growth trajectory for Core Scientific. The stock has also demonstrated robust performance, with a total price return of 25.64% over the last three months and is trading near its peak at approximately 97.93% of its 52-week high.

Although the company has faced challenges regarding profitability, analysts forecast that Core Scientific is on the verge of achieving profitability this year, which could further bolster upward momentum in its stock performance.

Frequently Asked Questions

What recent change did Canaccord Genuity make regarding Core Scientific?

Canaccord Genuity raised its price target for Core Scientific shares to $17.00 from $16.00 while keeping a Buy rating.

How much power has CoreWeave contracted with Core Scientific?

CoreWeave has contracted an additional 118 MW, bringing the total power under contract to 500 MW for critical data center operations.

What is the expected revenue impact from the new contract with CoreWeave?

The new agreement with CoreWeave is projected to contribute approximately $2.0 billion to Core Scientific over a 12-year span.

What financial moves has Core Scientific made recently?

The company recently sold 375 bitcoins and repaid $267 million in high-interest debt, aiding in strengthening its financial position.

Is Core Scientific currently profitable?

Core Scientific is not profitable at the moment, but analysts predict it will achieve profitability this year.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Excellence in Actuarial Science: SCOR Awards 2025

Updated Category News Views 116

SCOR’s Actuarial Awards 2025: A Celebration of Innovation For nearly 30 years, SCOR has consistently honored exemplary research in actuarial science through its prestigious Actuarial Awards. Across six countries, these awards seek to inspire progress in the field, fostering advancements that improve our understanding of risk. Encouraging Research and Excellence The SCOR...

Continue Reading
Gentex Corporation Announces Earnings Release Date for 2024

Updated Category News Views 190

Gentex Corporation Announces Fourth Quarter Earnings Release Gentex Corporation (NASDAQ: GNTX), a prominent supplier of advanced technology solutions including digital vision and connected car systems, has scheduled the release of its financial results for the fourth quarter and the year-end of 2024. Investors and stakeholders should mark their calendars for January 31,...

Continue Reading
Lockton's Strategic Move in Saudi Arabia with New Leadership

Updated Category News Views 197

Lockton's Expansion into Saudi Arabia Kansas City, Mo. – Lockton, recognized as the foremost privately held independent insurance brokerage, has embarked on a significant journey by expanding its operations into Saudi Arabia. This strategic move marks an essential development for Lockton, as it enhances its presence in the Middle East and aligns with its overarching...

Continue Reading
Revolutionizing Defense: AMIAD and Dassault Aviation Unite

Updated Category News Views 158

Partnership Between AMIAD and Dassault Aviation Leading the Way in Defense Innovation At a recent aerospace gathering, a significant partnership was forged as Pascale Lohat, the Senior Executive VP of Engineering at Dassault Aviation, and Bertrand Rondepierre, Director of the French Agency for AI in Defense (AMIAD), came together to sign a memorandum of understanding....

Continue Reading
Innovative Trauma Solutions by Globus Medical Enhance Patient Care

Updated Category News Views 133

Globus Medical, Inc. (NYSE: GMED) made waves in the orthopedic trauma sector back in 2024 with some heavy-hitting product launches. They introduced several groundbreaking systems, including the TENSOR™ Suture Button System—their first foray into suture-based innovations, which snagged 510(k) clearance from the FDA. You know that buzz on the trading floor? It was...

Continue Reading